Edit |   |
---|---|
Antigenic Specificity | RSPO3, Human (Rosmantuzumab biosimilar) |
Clone | Rosmantuzumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, FCM, IP, IF, FuncS |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human RSPO3 Recombinant Antibody. Rosmantuzumab (INN, development code OMP-131R10) is a humanized monoclonal antibody designed for the treatment of cancer. This drug was developed by OncoMed Pharmaceuticals. |
Immunogen | n/a |
Other Names | Anti-RSPO3 Recombinant Antibody, Research Grade Rosmantuzumab, Anti-Human RSPO3 Recombinant Antibody, OMP-131R10, Antibody Drug Analogues, Monoclonal Antibody, YR1437, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1684393-04-1 |
Catalog # | YR1437 |
Price | please inquire |
Order / More Info | RSPO3, Human (Rosmantuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |